Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2002
04/25/2002US20020048559 Copolymer and process for preparing the same
04/25/2002US20020048558 Topical delivery systems for active agents
04/25/2002US20020048551 Nutritional supplements that are encapsulated in lipid vesicles for administration as an aerosol or liquid droplet spray.
04/25/2002US20020047058 At least one composition of media bodies provides fragments of milling media bodies that are retained with the milled solid substrate particles in the form of a synergetic commixture produced in the milling process.
04/25/2002US20020046750 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
04/25/2002DE10146009A1 Material for producing fibrinolytic and/or antibacterial products comprises a partially dehydrated molecular sieve loaded with active agent(s) and incorporated into a tissue-compatible matrix
04/25/2002DE10049147A1 Haarwachsprodukt mit Wachsen, nicht-flüchtigen Ölen und flüchtigen, hydrophoben Stoffen Hair wax product with waxes, non-volatile oils and volatile, hydrophobic substances
04/25/2002DE10045343A1 Augenarzneimittel Eye medicines
04/25/2002DE10034673C1 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung Dermal application system for aminolevulinic acid and its use
04/25/2002CA2689856A1 Composition and method for stable injectable liquids
04/25/2002CA2464092A1 Electroprocessing in drug delivery and cell encapsulation
04/25/2002CA2426697A1 Method for making very fine particles consisting of a principle inserted in a host molecule
04/25/2002CA2426175A1 Stable oral formulation containing benzimidazole derivative
04/25/2002CA2426083A1 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis
04/25/2002CA2425900A1 Novel medicinal herbal composition for treating liver diseases and hiv
04/25/2002CA2425831A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
04/25/2002CA2425310A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol
04/25/2002CA2425196A1 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
04/25/2002CA2424345A1 Liposomal formulation of mitoxantrone
04/25/2002CA2423469A1 Methods and products related to pulmonary delivery of polysaccharides
04/24/2002EP1199079A2 Use of plant extract for treatment and prevention of sore throats
04/24/2002EP1199077A1 Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
04/24/2002EP1199073A1 Aminoethanesulfonic acid-containing preparations
04/24/2002EP1198995A1 Anti-stress composition for incorporation in nutritional carriers
04/24/2002EP1198570A1 Monomeric protein of the tgf-beta family
04/24/2002EP1198494A1 Preparations that are devoid of cross-linking agents
04/24/2002EP1198490A1 Neutral lipopolymer and liposomal compositions containing same
04/24/2002EP1198488A1 Biodegradable block copolymers with modifiable surface
04/24/2002EP1198322A1 Apparatus and methods for alternating laser treatment of pharmaceutical dispensers
04/24/2002EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
04/24/2002EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines
04/24/2002EP1198228A2 Release of poorly soluble agents
04/24/2002EP1198227A1 Method for producing quickly decomposable solid pharmaceutical preparations
04/24/2002EP1198226A1 Mesalazine controlled release oral pharmaceutical compositions
04/24/2002EP1198225A1 Epothilone compositions
04/24/2002EP1198224A1 Formulations of steroid solutions for inhalatory administration
04/24/2002EP1198223A2 Ophthalmic composition comprising ketotifen
04/24/2002EP0853494B1 Oil-water emulsifiers
04/24/2002EP0818992B1 Procedure for encapsulating nsaids
04/24/2002EP0801559B1 Process for the preparation of oral dosage-forms containing a beta-lactam antibiotic
04/24/2002EP0789557B1 Propellant mixture for aerosol formulation
04/24/2002EP0743860B1 Preparation of hollow microcapsules
04/24/2002EP0621877B2 Esters of pectic and pectinic acid
04/24/2002CN2487379Y Special machine for making stype
04/24/2002CN1346393A Adhesives
04/24/2002CN1346363A The novel antisense-oligos with better stability and antisense effect
04/24/2002CN1346360A Phosphoramidate, and mono-di, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1-methanol as antiviral agents
04/24/2002CN1346356A 治疗性的核苷化合物 Therapeutic nucleoside compound
04/24/2002CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof
04/24/2002CN1346283A External coated chewing gum products
04/24/2002CN1346276A Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria
04/24/2002CN1346274A Formulation comprising testosteron undecanoate and castor oil
04/24/2002CN1346273A Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
04/24/2002CN1346270A Compositions having improved stability
04/24/2002CN1346265A Preparations for percutaneous absorption
04/24/2002CN1346262A Antimicrobial wipes which provide improved immediate germ reduction
04/24/2002CN1346257A Liquid dispersion polymer composition, their preparation and their use
04/24/2002CN1346252A Prolonged release bioadhesive vaginal gel dosage form
04/24/2002CN1345597A Extract of free anthraquinone extracted from rhubarb and preparation process thereof
04/24/2002CN1345595A Aerosol for oral cavity health care
04/24/2002CN1345592A Productive technology for producing Jiatong powder injection
04/24/2002CN1345588A No-stinking fish-oil composite micro-capsule and preparation process
04/24/2002CN1345586A Medicine for relieving itching and detumescence
04/24/2002CN1345585A Process for preparing micropowder of cell rupture cable for raising Chinese medicine availability
04/24/2002CN1345584A Process for preparing non-aqueous Chinese medicine compount injecta
04/24/2002CN1083459C Process for preparing polymer powders redispersible in aqueous solution and prepared polymer powders
04/24/2002CN1083449C Nonionic vitamin E derivatives and method for prparation thereof, and polymeric amphiphilic vesicles made therefrom
04/24/2002CN1083279C Gel form of a vaccine and preparation process thereof
04/24/2002CN1083277C Thrat smoothing candy made of starculia scaphigera
04/24/2002CN1083275C Medicine for treating breast tuomor and carbuncle and preparation method thereof
04/24/2002CN1083268C Ointment for treating burn and scald and promoting tissue regeneration
04/24/2002CN1083267C Compositions of cartaegus species, medicaments and their use
04/24/2002CN1083266C Total parenteral nutrition solution containing water-soluble vitamin B
04/24/2002CN1083265C Improved pharmaceutical formulations containing ibuprofen and codeine
04/24/2002CN1083263C Use of melatonin for treating patients suffering from drug addiction
04/24/2002CN1083262C Composition of L-dopa esters
04/24/2002CN1083260C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
04/24/2002CN1083259C Trans dermal matrix system
04/23/2002US6377847 Iontophoretic drug delivery device and reservoir and method of making same
04/23/2002US6376657 Pharmaceutical compositions having appetite suppressant activity
04/23/2002US6376644 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
04/23/2002US6376545 Tablet
04/23/2002US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases
04/23/2002US6376504 Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity
04/23/2002US6376486 Methods of inhibiting sphincter incontinence
04/23/2002US6376481 Solid oral dosage form comprising support having given surface area range such as silicon dioxide, a stanol ester to reduce cholesterol, and a mixed micelle surfactant system
04/23/2002US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders
04/23/2002US6376461 Sustained-release preparation
04/23/2002US6376248 Peptide-enhanced transfections
04/23/2002US6376242 Reduce the number of circulating platelets to low or below normal levels.
04/23/2002US6376219 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
04/23/2002US6375994 Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
04/23/2002US6375990 Iontophoretically delivering lithium
04/23/2002US6375988 Drug composition with controlled drug release rate
04/23/2002US6375987 Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
04/23/2002US6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
04/23/2002US6375985 System and method for producing drug-loaded microparticles
04/23/2002US6375984 Aqueous-based pharmaceutical composition
04/23/2002US6375983 Microencapsulated fragrances and method for preparation
04/23/2002US6375982 Rapid-melt semi-solid compositions, methods of making same and method of using same